Clinical Trial Update: Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer [NA]

View source ↗

Summary

This clinical trial update reports results for an adjuvant triple-drug regimen (docetaxel, vinorelbine, and bevacizumab) in patients with resected stage I-III n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Navelbine (vinorelbine)
• Taxotere (docetaxel)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | NA | Status: COMPLETED | Results posted: 2015-11-20